Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
Phase 4
- Conditions
- Diabetes Type II
- First Posted Date
- 2015-02-11
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT02361489
- Locations
- 🇺🇸
Geisinger, Wilkes Barre, Pennsylvania, United States
Effectiveness of V-Goâ„¢ for Patients With Diabetes in a Real-world Setting
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2011-03-31
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT01326598
- Locations
- 🇺🇸
San Diego Coastal Endocrinology Group, Chula Vista, California, United States
🇺🇸Nancy J. Bohannon Med. Corp, San Francisco, California, United States
🇺🇸Western Connecticut Health Network, Inc., Danbury, Connecticut, United States
Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device
Phase 4
Terminated
- Conditions
- Type 1 DiabetesType 2 Diabetes
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2007-12-06
- Lead Sponsor
- Valeritas, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00453934
- Locations
- 🇺🇸
Diabetes and Glandular Research, San Antonio, Texas, United States
News
No news found